Tonix Pharmaceuticals Holding Corp. (TNXP) ownership: Top institutional holder: BlackRock, Inc. ($13.31M). Insider activity: Net Seller (3 buys, 17 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 968177.00 | $13.31M | 2026-03-31 |
| VANGUARD GROUP INC | 673605.00 | $10.52M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 518650.00 | $7.13M | 2026-03-31 |
| CITADEL ADVISORS LLC | 468712.00 | $6.44M | 2026-03-31 |
| Jones Hill Capital LP | 452116.00 | $6.22M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 313291.00 | $4.31M | 2026-03-31 |
| Balyasny Asset Management L.P. | 313082.00 | $4.30M | 2026-03-31 |
| UBS Group AG | 231678.00 | $3.19M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-30 | |
| Buy | null | 2026-06-12 | |
| Buy | null | 2026-06-09 | |
| Buy | null | 2026-06-08 | |
| Sell | null | 2026-05-12 | |
| Sell | null | 2026-05-12 | |
| Sell | null | 2026-05-12 | |
| Sell | null | 2026-05-12 |
Back to TNXP overview · TNXP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.